Ion Channel Drug Discovery

/Tag: Ion Channel Drug Discovery

World Preclinical Congress 2019

2019-02-12T16:31:00+00:00

Metrion Biosciences' CSO Dr Marc Rogers will be attending the World Preclinical Congress in Boston from 17th to 20th June taking place at the Seaport World Trade Centre. Marc will be available to discuss Metrion's services and please email info@metrionbiosciences.com to make an appointment. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within [...]

World Preclinical Congress 20192019-02-12T16:31:00+00:00

Nanion US User Meeting 2019

2019-04-10T10:56:53+00:00

Metrion Biosciences' Chief Scientific Officer, Dr Marc Rogers will be presenting at the Nanion User Meeting in Boston to be held at the Boston Marriott Long Wharf Hotel on 28th and 29th May 2019. Marc will be available during the event to discuss Metrion's range of ion channel drug discovery services. Please email info@metrionbiosciences.com to [...]

Nanion US User Meeting 20192019-04-10T10:56:53+00:00

University of Copenhagen – Ion Channel Symposium

2019-04-10T11:08:58+00:00

Metrion Biosciences' Business Manager Dr John Ridley and Senior Scientist Dr Edward Humphries will be attending the University of Copenhagen Ion Channel Forum on 23rd and 24th May 2019. Please contact info@metrionbiosciences.com to arrange a meeting with John and Edd at the event. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the [...]

University of Copenhagen – Ion Channel Symposium2019-04-10T11:08:58+00:00

Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer

2019-04-08T08:01:46+00:00

Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer Cambridge, UK, 08 April 2019: Metrion Biosciences (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Dr Andrew Southan as Chief Executive Officer, with immediate effect. Dr Southan was previously the Company’s Chief Operating Officer. Dr Southan joined [...]

Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer2019-04-08T08:01:46+00:00

Metrion Biosciences closes funding round

2019-04-01T08:22:36+00:00

Metrion Biosciences Closes Funding Round Includes investment from o2h Ventures Therapeutics Fund Funding to support expansion of ion channel screening capabilities and continued research into potential drugs for auto-immune diseases Cambridge, UK, 01 April 2019: Metrion Biosciences Ltd (“Metrion”), the specialist ion channel contract research and drug discovery company, announced today that it has completed [...]

Metrion Biosciences closes funding round2019-04-01T08:22:36+00:00

The Biophysical Society 2019 Satellite Meeting – Drug Discovery for Ion Channels XIX

2019-02-06T16:12:06+00:00

Metrion Biosciences are sponsoring this years' Biophysical Society Satellite event 'Drug Discovery for Ion Channels XIX' in Baltimore on Friday 1st March 2019. Metrion's CSO Dr Marc Rogers and Sales and Marketing Manager Dr Sophie Rose will be attending. Marc Rogers will be presenting "Successful Development of State-dependent Voltage-gated Ion Channel Modulators with in vivo [...]

The Biophysical Society 2019 Satellite Meeting – Drug Discovery for Ion Channels XIX2019-02-06T16:12:06+00:00

The Biophysical Society 2019 meeting

2019-02-06T15:28:08+00:00

Metrion Biosciences are attending and exhibiting at Booth #348 at The 65th Annual meeting of the Biophysical Society in Baltimore, Maryland. Metrion will be exhibiting from Saturday 2nd March to Wednesday 6th March at stand number 348 in the Exhibits hall and the interactive floor plan can be found here. Metrion's CSO Dr Marc Rogers [...]

The Biophysical Society 2019 meeting2019-02-06T15:28:08+00:00

An Interview with Professor Alistair Mathie

2019-03-01T15:27:50+00:00

Professor Alistair Mathie, one of Metrion's previous external speakers, gives a perspective below regarding his research into two pore domain potassium channels and his involvement in a collaborative project focused on the detection of atrial fibrillation (AF). On the latter topic, Metrion would like to offer its congratulations to Alistair and his colleagues on the Pharmacists [...]

An Interview with Professor Alistair Mathie2019-03-01T15:27:50+00:00

ELRIG: Pharmaceutical Flow Cytometry and Imaging

2018-10-08T09:07:58+00:00

Sophie Rose will be attending ELRIG: Pharmaceutical Flow Cytometry and Imaging. Please email info@metrionbiosciences.com to schedule a convenient time for a discussion. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities [...]

ELRIG: Pharmaceutical Flow Cytometry and Imaging2018-10-08T09:07:58+00:00

Ninth Nanion Users Meeting, Munich

2018-10-16T11:14:35+00:00

Metrion Biosciences will be attending the ninth Nanion Technologies User Meeting in Munich, Germany 25-26th October 2018. Metrion's Sam Manyweathers will be presenting:- "Designing multiple assay protocols for ligand-gated ion channel targets using the stacked tip feature on the Patchliner". Nanion feature a dedicated area of their website to collaborative partners and Metrion is delighted to [...]

Ninth Nanion Users Meeting, Munich2018-10-16T11:14:35+00:00